Dexmedetomidine improves the outcomes for pediatric severe sepsis with mechanical ventilation

Chun Zhao1, Yi Yin1, Tianxin Zhang2

  • 1Department of Pediatric intensive care unit, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong Province, P.R. China.

BMC Pediatrics
|August 18, 2023
PubMed

Insights

Dexmedetomidine sedation in children with severe sepsis and mechanical ventilation reduced 28-day mortality. This sedative may improve outcomes in pediatric severe sepsis patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pharmacology
  • Sepsis Research

Background:

  • Severe sepsis poses a significant mortality risk in children.
  • Dexmedetomidine, a sedative, has demonstrated mortality benefits in adult severe sepsis.
  • The efficacy of dexmedetomidine in pediatric severe sepsis remains under investigation.

Purpose of the Study:

  • To investigate the impact of dexmedetomidine on mortality and clinical outcomes in mechanically ventilated children with severe sepsis.
  • To compare outcomes between children receiving dexmedetomidine and those not receiving it for sedation.

Main Methods:

  • Retrospective cohort study of children with severe sepsis requiring mechanical ventilation (2016-2020).
  • Propensity score matching used to create comparable dexmedetomidine and non-dexmedetomidine groups (61 children each).
  • Primary outcome: 28-day mortality. Secondary outcomes: acute kidney injury, ventilator-free days, PICU/hospital length of stay.

Main Results:

  • Dexmedetomidine group had significantly lower 28-day mortality (9.84% vs. 26.23%, P=0.008).
  • The dexmedetomidine group showed lower day 7 neurological and renal sub-scores and improved day 3/7 serum creatinine levels.
  • No significant differences observed in acute kidney injury incidence, ventilator-free days, or lengths of PICU/hospital stays.

Conclusions:

  • Dexmedetomidine treatment is associated with improved outcomes in pediatric severe sepsis.
  • Consideration of dexmedetomidine as a sedation strategy in this patient population is warranted.
  • Further research may explore specific benefits and optimal use in children.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
154
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
511
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
475
Mechanical Ventilation III: Noninvasive Ventilation01:23

Mechanical Ventilation III: Noninvasive Ventilation

Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
149